pyrimethamine has been researched along with Embryopathies in 17 studies
Maloprim: contains above 2 cpds
| Excerpt | Relevance | Reference |
|---|---|---|
| " In case of maternal contamination after 33 weeks of pregnancy, pyrimethamine-sulfadiazine combination should be used in spite of its potential toxicity." | 3.67 | New perspectives in the chemoprophylaxis of toxoplasmosis. ( Garin, JP; Piens, MA, 1989) |
| "Effective intermittent preventive treatment in pregnancy (IPTp) diminishes placental malaria (PM) and its subsequent malaria-associated morbidity." | 2.50 | Pregnancy-associated malaria and malaria in infants: an old problem with present consequences. ( Abellana, R; Cot, M; Moya-Alvarez, V, 2014) |
| "Intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is protective against malaria but may also affect hematopoiesis and contribute to fetal anemia." | 1.38 | The effects of malaria and intermittent preventive treatment during pregnancy on fetal anemia in Malawi. ( Chaluluka, E; Feng, G; Meshnick, SR; Molyneux, ME; Rogawski, ET; Rogerson, SJ, 2012) |
| "Fifty-seven cases of congenital toxoplasmosis were demonstrated (34." | 1.31 | Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. ( Berrebi, A; Bessières, MH; Bloom, MC; Cassaing, S; Courjault, C; Rolland, M; Roques, C; Séguéla, JP, 2001) |
| "We describe the case of a patient with systemic lupus erythematosus, treated by corticosteroids, who presented during two successive pregnancies with serological reactivation of toxoplasmosis associated with fetal lesions." | 1.29 | Recurrent congenital toxoplasmosis in a woman with lupus erythematosus. ( Blanc, B; Boubli, L; Casta, M; Chagnon, C; Cravello, L; D'Ercole, C; Franck, J; Harle, JR; Leclaire, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moya-Alvarez, V | 1 |
| Abellana, R | 1 |
| Cot, M | 1 |
| Cohee, LM | 1 |
| Kalilani-Phiri, L | 1 |
| Boudova, S | 1 |
| Joshi, S | 1 |
| Mukadam, R | 1 |
| Seydel, KB | 1 |
| Mawindo, P | 1 |
| Thesing, P | 1 |
| Kamiza, S | 1 |
| Makwakwa, K | 1 |
| Muehlenbachs, A | 1 |
| Taylor, TE | 1 |
| Laufer, MK | 1 |
| Rogawski, ET | 1 |
| Chaluluka, E | 1 |
| Molyneux, ME | 1 |
| Feng, G | 1 |
| Rogerson, SJ | 1 |
| Meshnick, SR | 1 |
| CONTARDOASTABURAGA, R | 1 |
| HICKL, EJ | 1 |
| MOHR, U | 1 |
| MARTIUS, G | 1 |
| McCabe, R | 1 |
| Chirurgi, V | 1 |
| D'Ercole, C | 1 |
| Boubli, L | 1 |
| Franck, J | 1 |
| Casta, M | 1 |
| Harle, JR | 1 |
| Chagnon, C | 1 |
| Cravello, L | 1 |
| Leclaire, M | 1 |
| Blanc, B | 1 |
| Schoondermark-van de Ven, EM | 1 |
| Melchers, WJ | 1 |
| Galama, JM | 1 |
| Meuwissen, JH | 1 |
| Eskes, TK | 1 |
| Uche-Nwachi, EO | 1 |
| Caxton-Martins, AE | 1 |
| Villena, I | 1 |
| Quereux, C | 1 |
| Pinon, JM | 1 |
| Bessières, MH | 1 |
| Berrebi, A | 1 |
| Rolland, M | 1 |
| Bloom, MC | 1 |
| Roques, C | 1 |
| Cassaing, S | 1 |
| Courjault, C | 1 |
| Séguéla, JP | 1 |
| Kräubig, H | 1 |
| Petter, C | 1 |
| Bourbon, J | 1 |
| Wilson, CB | 1 |
| Piens, MA | 1 |
| Garin, JP | 1 |
| Rosenfeld, JA | 1 |
| Sadoff, L | 1 |
3 reviews available for pyrimethamine and Embryopathies
| Article | Year |
|---|---|
Pregnancy-associated malaria and malaria in infants: an old problem with present consequences.
Topics: Adult; Africa South of the Sahara; Antimalarials; Comorbidity; Complement Activation; Developmental | 2014 |
Issues in toxoplasmosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Clindamycin; Drug Therapy, Combination; Encephalitis | 1993 |
[Toxoplasmosis and pregnancy].
Topics: Drug Therapy, Combination; Female; Fetal Diseases; Germany, West; Humans; Infant, Newborn; Pregnancy | 1976 |
14 other studies available for pyrimethamine and Embryopathies
| Article | Year |
|---|---|
Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Asymptomatic Diseases | 2014 |
The effects of malaria and intermittent preventive treatment during pregnancy on fetal anemia in Malawi.
Topics: Anemia, Neonatal; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Fetal Blood; Fe | 2012 |
[UVEITIS AND TOXOPLASMOSIS].
Topics: Adrenal Cortex Hormones; Betamethasone; Child; Chile; Chorioretinitis; Complement Fixation Tests; De | 1964 |
[ANIMAL EXPERIMENTAL STUDIES ON THE PROBLEM OF FETAL DAMAGE BY PYRIMETHAMINE].
Topics: Abnormalities, Drug-Induced; Animal Experimentation; Animals; Female; Fetal Diseases; Humans; Matern | 1964 |
Recurrent congenital toxoplasmosis in a woman with lupus erythematosus.
Topics: Adult; Amniotic Fluid; Animals; Anti-Infective Agents; Antibodies, Protozoan; Female; Fetal Diseases | 1995 |
Prenatal diagnosis and treatment of congenital Toxoplasma gondii infections: an experimental study in rhesus monkeys.
Topics: Amniotic Fluid; Animals; Anti-Infective Agents; Disease Models, Animal; DNA, Protozoan; DNA, Ribosom | 1997 |
Sulfadoxine-pyrimethamine embryopathy in Wistar rats.
Topics: Animals; Antimalarials; Drug Combinations; Embryo, Mammalian; Female; Fetal Diseases; Folic Acid Def | 1998 |
Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
Topics: Anti-Infective Agents; Antiprotozoal Agents; Female; Fetal Diseases; Humans; Pregnancy; Pyrimethamin | 1998 |
Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cohort Studies; Female; Fetal Blood; Fetal Dis | 2001 |
Foetal red cell macrocytosis induced by pyrimethamine; its teratogenic role.
Topics: Abnormalities, Drug-Induced; Animals; Erythrocytes; Erythrocytes, Abnormal; Female; Fetal Diseases; | 1975 |
Treatment of congenital toxoplasmosis during pregnancy.
Topics: Female; Fetal Diseases; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; P | 1990 |
New perspectives in the chemoprophylaxis of toxoplasmosis.
Topics: Chorioretinitis; Drug Combinations; Female; Fetal Diseases; Humans; Immune Tolerance; Infant, Newbor | 1989 |
Maternal and congenital toxoplasmosis. Is prevention possible?
Topics: Amniocentesis; Female; Fetal Blood; Fetal Diseases; Humans; Pregnancy; Prenatal Diagnosis; Pyrimetha | 1988 |
Letter: Antimalarial drugs and Burkitt's lymphoma.
Topics: Antimalarials; Burkitt Lymphoma; Child; Female; Fetal Diseases; Humans; Maternal-Fetal Exchange; Pre | 1973 |